• Anatolii I. Yaroshenko Zaporizhzhia National University Zaporizhzhia State Medical University, Ukraine
  • Tamara V. Panasenko Zaporizhzhia National University, 66 Zhukovskoho Str., Zaporizhzhia, Ukraine
  • Yevhen S. Pruhlo Zaporizhzhia State Medical University, Ukraine



gas chromatography, mass spectrometry, heterocyclic compounds, 1, 2, 4-triazole derivatives, retention time, response, peak area, symmetry factor, melting point, polarity


Pharmaceutical products require appropriate quality control, which comprises a set of tests aimed at the determination of assays of the substances. Chromatographic methods are one of the most abundant analytical methods applied in routine analyses of pharmaceuticals. Information on the behavior of the compounds under certain analytical conditions is valuable in the process of analytical method development. This work was aimed at revealing the impact of substituents of various natures at two positions of triazole ring on the behavior of new 3-thio-1,2,4-triazoles under GC-MS conditions and evaluating the applicability of GC-MS method for the analysis of these compounds. Gas chromatography was used in combination with mass spectrometry. New 1,2,4-triazole derivatives were obtained at the Department of Natural Sciences for International Students and Toxicological Chemistry of Zaporizhzhia State Medical University. For the experiment, two groups of compounds were formed, each having different substituents at C-3 and C-5 of triazole molecule, respectively. The analysis was held using Agilent 7890B GC system coupled with Agilent 5977B mass selective detector. Compounds were separated on a non-polar column. The following parameters were assessed and compared for identification and study of chromatographic behavior of the compounds: mass spectra, retention times, symmetry factors, and relative responses (against reference compound). It was shown that there is no direct relation between melting point and retention time; instead, the nature of substituents significantly affects the chromatographic behavior. The strongest response belongs to compounds that have phenyl moiety at C-5 and alkyl substituent attached through thiol group at C-3 of the triazole ring. Thiophen-2-yl and methyl at C-5, as well as acetate and ester groups attached through thiol group at C-3 of the cycle, decrease chromatographic response. GC-MS can be applied for the analysis of biologically active 1,2,4-triazoles, though with several limitations. The higher the polarity of the compound, the worse the response and peak shape; these circumstances complicate GC-MS analysis of 1,2,4-triazole derivatives. Apart from providing information on physicochemical properties of the compounds, the obtained experimental data provide some valuable insights into permeability of the new triazole derivatives through biological membranes, which could be useful in drug design.


Cuzick, J., Sestak, I., Forbes, J. F., Dowsett, M., Knox, J., Cawthorn, S., Saunders, C., Roche, N., Mansel, R. E., von Minckwitz, G., Bonnanni, B., Palva, T., Howell, A. (2014). Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): An international, double-blind, randomised placebo-controlled trial. Lancet, 383(9922), 1041–1048.

Cardoso, N. N. R., Alviano, C. S., Blank, A. F., Romanos, M. T. V., Fonseca, B. B., Rozental, S., Rodrigues, I. A., Alviano, D. S. (2016). Synergism effect of the essential oil from Ocimum basilicum var. Maria Bonita and its major components with fluconazole and its influence on ergosterol biosynthesis. J. Evidence-Based Complementary Altern. Med., 2016, 5647182,


Uppuluri, C., Shaik, A. S., Han, T., Nayak, A., Nair, K. J., Whiteside, B. R., Nalluri, B. N., Das, D. B. (2017). Effect of microneedle type on transdermal permeation of rizatriptan. AAPS PharmSciTech, 18(5), 1495–1506.

Lin, C.-H., Chou, P.-H., Chen, P.-J. (2014). Two azole fungicides (carcinogenic triadimefon and non-carcinogenic myclobutanil) exhibit different hepatic cytochrome P450 activities in medaka fish. J. Hazard. Mater., 227, 150–158.

Damião, M. C. F. C. B., Galaverna, R., Kozikowski, A. P., Eubanksc, J., Pastre, J. C. (2017). Telescoped continuous flow generation of a library of highly substituted

-thio-1,2,4-triazoles. React. Chem. Eng., 2(6), 896–907.

Kaur, P., Chawla, A. (2017). 1,2,4-Triazole: A review of pharmacological activities. Int. Res. J. Pharm., 8(7),


Lima, D. M., Junior, G. P. N., Ferri, P. H., Santos, S. C. (2005). Determination of fluconazole in serum and amniotic fluid of rats by gas chromatography/mass spectrometry (GC/MS). Braz. J. Pharm. Sci., 41(2),


Raman, N. V. V. S. S., Prasad, A. V. S. S., Reddy, K. R., Ramakrishna, K. (2017). Determination of 1-bromo-3-chloropropane, 1-(4-nitrobenzyl)-1H-1,2,4-triazole, and 1-(bromomethyl)-4-nitrobenzene in rizatriptan benzoate. Chromatographia, 80(3), 447–452.

Flieger, J., Kowalska, A., Pizon, M., Plech, T., Łuszczki, J. (2015). Comparison of mouse plasma and brain tissue homogenate sample pretreatment methods prior to high-performance liquid chromatography for a new 1,2,4-triazole derivative with anticonvulsant activity. J. Sep. Sci., 38(12), 2007–2192.

Parlak, A. E., Çelik, S., Karatepe, M., Koparir, M. (2015). The effects of 5,5'-butane-1,4-diylbis{2-[(4-benzylpiperazin-1-yl)methyl]-4-ethyl-2,4-dihydro-3H-1,2,4-triazole-3-thione} on Mda level and vitamins in serum, liver and kidney of rats. NWSA-Physical Sciences, 10(2), 29–36.

Flieger, J., Tatarczak-Michalewska, M., Wujec, M., Pitucha, M., Swieboda, R. (2015). RP-HPLC analysis and in vitro identification of antimycobacterial activity of novel thiosemicarbazides and 1,2,4-triazole derivatives. J. Pharm. Biomed. Anal., 107, 501–511.

Center of Medical Research Information and Patent and Licensing Practice of Ukraine. (2017). [Determination of the active pharmaceutical ingredient of piperidinium ([5-(2-furanyl)-4-phenyl-4?-1,2,4-triazol-3-yl]thio)acetate and its impurities using HPLC-DMD] (Ukrmedpatentinfo methodological recommendations reference no. 146.16/28.17). Kyiv, Ukraine: Ukrmedpatentinfo (In Ukrainian).

Cetin, A., Geçibesler, I. H. (2015). Evaluation as antioxidant agents of 1,2,4-triazole derivatives: Effects of essential functional groups. J. Appl. Pharm. Sci., 5(6), 120–126.

Zamani, K., Faghihi, K., Sangi, M. R., Zolgharnein, J. (2003). Synthesis of some new substituted 1,2,4-triazole and 1,3,4-thiadiazole and their derivatives. Turk. J. Chem., 27, 119–125.

Salionov, V. A., Varynskyi, B. A., Parchenko, V. V. (2015). Mass-spectrometric fragmentation of sodium 2-(4-methyl-5-(thiophene-2-yl)-4H-1,2,4-triazole-3-ylthio)acetate. Problems of Pharmacy, 5(92), 93–96.

Li, J. J. (Ed). (2013). Heterocyclic chemistry in drug discovery. Hoboken, USA: John Wiley & Sons, Inc.

Directorate for the Quality of Medicines & Healthcare of the Council of Europe. (2013). European Pharmacopoeia (8th ed.; Vol. 1). Strasbourg, France: Council of Europe.

Leeson, P. D. (2016). Molecular inflation, attrition and the rule of five, advanced drug delivery reviews. Adv. Drug Delivery Rev., 101, 22–33.

Klose, M. H. M., Theiner, S., Varbanov, H. P., Hoefer, D., Pichler, V., Galanski, M., Meier-Menches, S. M., Keppler, B. K. (2018). Development and validation of liquid chromatography-based methods to assess the lipophilicity of cytotoxic platinum(IV) complexes. Inorganics, 6(4), 130.

Hawrył, A. M., Popiołek, Ł. P., Hawrył, M. A., Świeboda, R. S., Niejedlia, M. A. (2015). Chromatographic and calculation methods for analysis of the lipophilicity of newly synthesized thiosemicarbazides and their cyclic analogues 1,2,4-triazol-3-thiones. J. Braz. Chem. Soc., 26(8), 1617–1624.

Ciura, K., Dziomba, S., Nowakowska, J., Markuszewski, M. J. (2017). Thin layer chromatography in drug discovery process. J. Chromatogr. A., 1520, 9–22.

Czyrski, A. (2018). Determination of the lipophilicity of ibuprofen, naproxen, ketoprofen, and flurbiprofen with thin-layer chromatography. Journal of Chemistry, 2019, 3407091.

Del Ríoa, J. C., Marquesa, G., Linoa, A. G., Limab, C. F., Colodettec, J. L., GutiérrezaaInstituto, A. (2015). Lipophilic phytochemicals from sugarcane bagasse and straw. Ind. Crops Prod., 77, 992–1000.

Carson, M., Kerrigan, S. (2017). Quantification of suvorexant in urine using gas chromatography/mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 1040, 289–294.

Sahoo, C. K., Reddy, G. S., Reddy, B. V., Vojjala, A. (2018). Bioavailability enhancement for poorly soluble drugs: A review. Innoriginal International Journal of Sciences, 5(4), 1–6.

Ermondi, G., Caron, G. (2018). Block relevance (BR) analysis and polarity descriptors in property-based drug design. ADMET & DMPK, 6(3), 215–224.

Jones, S. (2015). GC method development [PowerPoint slides]. Retrieved from